ZANNES MARIA (President, CEO) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/24/2024ACC: 0001493152-24-003696
DirectorOfficer· President, CEO
Since Aug 2022
+24.54K
Net shares
Net buyer
$37.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
24.54K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.87K
Price / share
$1.58
Trade value
$18.75K
% of position
10.2%
10/1/2023
116.24K→128.10K
Common Stock
Direct
Shares
+12.67K
Price / share
$1.48
Trade value
$18.75K
% of position
9.9%
1/1/2024
128.10K→140.77K
Total
Net shares
+24.54K
Net value
$37.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2023 | A · Award | +11.87K | $1.58 | $18.75K | 10.2% | 116.24K | 128.10K |
| Common Stock Direct | 1/1/2024 | A · Award | +12.67K | $1.48 | $18.75K | 9.9% | 128.10K | 140.77K |
| Total | +24.54K | $37.50K | ||||||
Derivative Transactions0
No derivative transactions reported